Cargando…

Measuring Transparency to Improve Good Governance in the Public Pharmaceutical Sector.

Annotation

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: WHO
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Geneva : World Health Organization, 2009.
Temas:
Acceso en línea:Texto completo
Texto completo

MARC

LEADER 00000cam a2200000Mu 4500
001 EBOOKCENTRAL_ocn694342017
003 OCoLC
005 20240329122006.0
006 m o d
007 cr |n|---|||||
008 101227s2009 sz o 000 0 eng d
040 |a EBLCP  |b eng  |e pn  |c EBLCP  |d OCLCQ  |d S4S  |d OCLCQ  |d MERUC  |d YDXCP  |d DKDLA  |d OCLCQ  |d ZCU  |d ICG  |d OCLCO  |d OCLCF  |d OCLCQ  |d OCLCO  |d OCLCQ  |d DKC  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL 
019 |a 781625393 
020 |a 9789290217145 
020 |a 9290217146 
020 |a 9789290216827 
020 |a 9290216824 
029 1 |a AU@  |b 000048793494 
029 1 |a DEBBG  |b BV044144670 
029 1 |a DEBBG  |b BV044144671 
035 |a (OCoLC)694342017  |z (OCoLC)781625393 
043 |a a-jo--- 
050 4 |a HD9672 .L42 M43 2009 
082 0 4 |a 331 
049 |a UAMI 
100 1 |a WHO. 
245 1 0 |a Measuring Transparency to Improve Good Governance in the Public Pharmaceutical Sector. 
260 |a Geneva :  |b World Health Organization,  |c 2009. 
300 |a 1 online resource (79 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
505 0 |a COVER; TITLE; COPYRIGHT; Contents; Foreword; Preface; Acknowledgements; Executive summary; 1. Introduction; 2. Overview of the public pharmaceutical sector in Lebanon; 3. Methodology; 4. Results and data presentations; 5. Data analysis and discussion; 6. Recommendations; 7. Conclusions; 8. Resource documents; Annexes. 
588 0 |a Print version record. 
520 8 |a Annotation  |b In recent years, countries of the WHO Eastern Mediterranean Region have made significant achievements in the provision of health services. In the pharmaceutical field, countries have been striving to improve the structures and regulations pertaining to medicines and have progressed in many ways. However, there are still important challenges. The goal of the WHO Good Governance for Medicines programme is to improve the situation of medicines regulation and supply. National transparency assessment is the beginning of a process aimed at bringing about desirable and sustainable changes in the governance of the pharmaceutical sector. These reports present the findings of the first phase of the national Good Governance for Medicines programme in Jordan, Lebanon, Morocco, Pakistan and Syrian Arab Republic. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Pharmaceutical industry  |x Standards  |z Jordan. 
650 0 |a Pharmaceutical policy  |z Jordan. 
650 6 |a Industrie pharmaceutique  |x Normes  |z Jordanie. 
650 6 |a Médicaments  |x Politique gouvernementale  |z Jordanie. 
650 7 |a Pharmaceutical industry  |x Standards  |2 fast 
650 7 |a Pharmaceutical policy  |2 fast 
651 7 |a Jordan  |2 fast  |1 https://id.oclc.org/worldcat/entity/E39PBJgMCMwpB3Qrd9t7MBYHG3 
776 0 8 |i Print version:  |a WHO.  |t Measuring Transparency to Improve Good Governance in the Public Pharmaceutical Sector: Lebanon.  |d Geneva : World Health Organization, ©2009  |z 9789290216513 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=538062  |z Texto completo 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=538063  |z Texto completo 
938 |a EBL - Ebook Library  |b EBLB  |n EBL538063 
938 |a YBP Library Services  |b YANK  |n 3525447 
994 |a 92  |b IZTAP